The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry

Joren Maeremans1, Simon Walsh2, Paul Knaapen3

  • 1Faculty of Medicine and Life Sciences, Universiteit Hasselt, Hasselt, Belgium; Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Insights

The hybrid algorithm for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) demonstrates high success rates (86%) and low complication rates (2.6%) in a large multicenter registry. These findings support its broader adoption by trained operators.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • The hybrid algorithm for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) aims to enhance procedural success.
  • A lack of large, prospective multicenter studies has limited validation across diverse operator experiences.

Purpose of the Study:

  • To evaluate the real-world effectiveness and safety of the hybrid algorithm for CTO PCI.
  • To report procedural outcomes and complications in a broad patient population.

Main Methods:

  • Prospective enrollment of consecutive patients undergoing hybrid CTO PCI in 17 centers (January 2014 - October 2015).
  • Analysis of procedural techniques, success rates, and in-hospital complications.
  • Evaluation of primary and bailout strategy effectiveness.

Main Results:

  • 1,253 CTO-PCIs were performed in 1,177 patients, with an 86% overall procedure success rate and 2.6% major in-hospital complications.
  • Antegrade wire escalation was the most common primary strategy (77%), successful in 60%.
  • Bailout strategies, including antegrade dissection re-entry and retrograde approaches, showed success rates of 67% and 62%, respectively.

Conclusions:

  • The hybrid algorithm achieves high procedural and patient success rates with a low event rate.
  • Improved procedural characteristics support the wider use of the hybrid algorithm among trained CTO operators.
  • Further validation in diverse settings reinforces its clinical utility.
Abstract